(Q39340631)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22643066%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

title

EGFR status and EGFR ligand expression influence the treatment response of head and neck cancer cell lines (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22643066%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

1 reference

1 reference

head and neck carcinoma

1 reference

based on heuristic

inferred from title

author

Ann-Charlotte Johansson

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22643066%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

author name string

Adam Jedlinski

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22643066%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Anna Ansell

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22643066%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Karin Roberg

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22643066%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

publication date

29 May 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22643066%20AND%20SRC:MED&resulttype=core&format=json

Journal of Oral Pathology & Medicine

2 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22643066%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

volume

42

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22643066%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22643066%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

page(s)

26-36

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22643066%20AND%20SRC:MED&resulttype=core&format=json

Treatment of cancer of the head and neck

2 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2012.01177.X

The chemoradiation paradigm in head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2012.01177.X

Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2012.01177.X

The epidermal growth factor receptor ligands at a glance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2012.01177.X

Tobacco smoke stimulates the transcription of amphiregulin in human oral epithelial cells: evidence of a cyclic AMP-responsive element binding protein-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2012.01177.X

Amphiregulin and epiregulin mRNA expression in primary tumors predicts outcome in metastatic colorectal cancer treated with cetuximab

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2012.01177.X

Persistent activation of the Akt pathway in head and neck squamous cell carcinoma: a potential target for UCN-01.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2012.01177.X

Multiple genotypic aberrances associate to terminal differentiation-deficiency of an oral squamous cell carcinoma in serum-free culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2012.01177.X

Alcohol dehydrogenase 3 transcription associates with proliferation of human oral keratinocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2012.01177.X

Quantitative real-time PCR for the measurement of feline cytokine mRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2012.01177.X

Frequent overexpression of multiple ErbB receptors by head and neck squamous cell carcinoma contrasts with rare antibody immunity in patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2012.01177.X

Prognostic value of epidermal growth factor receptor expression in patients with advanced stage nasopharyngeal carcinoma treated with induction chemotherapy and radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2012.01177.X

The prognostic value of epidermal growth factor receptor is related to tumor differentiation and the overall treatment time of radiotherapy in squamous cell carcinomas of the head and neck.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2012.01177.X

K-ras mutations and benefit from cetuximab in advanced colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2012.01177.X

Mutations, expression and genomic instability of the H-ras proto-oncogene in squamous cell carcinomas of the head and neck

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2012.01177.X

Signaling via ErbB2 and ErbB3 associates with resistance and epidermal growth factor receptor (EGFR) amplification with sensitivity to EGFR inhibitor gefitinib in head and neck squamous cell carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2012.01177.X

Epidermal growth factor receptor status and persistent activation of Akt and p44/42 MAPK pathways correlate with the effect of cetuximab in head and neck and colon cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2012.01177.X

KRAS mutation status is predictive of response to cetuximab therapy in colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2012.01177.X

Gene copy number for epidermal growth factor receptor (EGFR) and clinical response to antiEGFR treatment in colorectal cancer: a cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2012.01177.X

Proteomic signatures of epidermal growth factor receptor and survival signal pathways correspond to gefitinib sensitivity in head and neck cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2012.01177.X

Prediction of sensitivity of advanced non-small cell lung cancers to gefitinib (Iressa, ZD1839).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2012.01177.X

Regulation of heparin-binding EGF-like growth factor by miR-212 and acquired cetuximab-resistance in head and neck squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2012.01177.X

Mutant epidermal growth factor receptor (EGFRvIII) contributes to head and neck cancer growth and resistance to EGFR targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2012.01177.X

Inhibition of the type III epidermal growth factor receptor variant mutant receptor by dominant-negative EGFR-CD533 enhances malignant glioma cell radiosensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2012.01177.X

Radiation-induced activation of a common variant of EGFR confers enhanced radioresistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2012.01177.X

Hepatocyte growth factor expression in EGFR mutant lung cancer with intrinsic and acquired resistance to tyrosine kinase inhibitors in a Japanese cohort.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2012.01177.X

10.1111/J.1600-0714.2012.01177.X

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22643066%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

1 reference